Invest in cancer research worldwide

Conception, design and realization by Iconlink, Zurich

Project Contribution

SWISS BRIDGE AWARD 2011

supporting high-quality cancer research projects in Europe

SWISS BRIDGE is a private foundation associated with the Swiss Cancer League, the Foundation Cancer Research Switzerland, and the International Union Against Cancer (UICC), and supports high-quality cancer research in Europe (www.swissbridge.ch). This year, eligible for funding are projects focusing on rare tumors* or childhood cancers.

Investigators from academic and cancer research institutions in Europe are invited to submit a note of intent for a new cancer research project on or before March 31st, 2011. The proposals will be screeened by an  international scientific committee. The principal investigators of a shortlist of between 6 and 8 projects will then be invited to submit (by email) a detailed research application by the end of July 2011. Upon peer review and recommendation from the scientific committee, up to 3 projects will receive funding amounting to a total support of  500,000 Swiss francs. The donors have earmarked 50 percent of the funds for Swiss projects.

The winners will be invited to a ceremony to be held at the end of October 2011.

The note of intent should be no longer than 6 pages (3,000 words) and should include:

  • the title of the project
  • the name, address and affiliation of the principal investigator
  • the domain of research (basic, clinical, psychosocial, epidemiological, translational, other – please specify)
  • the principal investigator’s short curriculum vitae
  • a support letter from their employer
  • the name(s), address(es) and affiliation(s) of the co-applicant(s)
  • the project period (max. 3 years)
  • the amount of financial support requested
  • a summary of the project (1-2 pages)
  • a list of up to 12 publications by the principal investigator and
  • a statement regarding the relevance and potential contribution of the project to cancer control (1-2 pages)

The note of intent must be transmitted by e-mail on or before March 31st, 2011 to:

swissbridge.dont-like-spam@ich-will-kein-spam.swisscancer.ch

Office of the Scientific Board of the Swiss Bridge Foundation
c/o Swiss Cancer League, P.O. Box 8219, CH-3001 Bern, Switzerland.

* Rare tumors are identified as those with incidence less than 6 per 100,000 persons/year.
  See also www.rarecare.eu.